Legal status by country
Is Retatrutide with cagrilintide legal?
Written by Aaron CuhaReviewed Sep 2026
How Retatrutide with cagrilintide is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Investigational, not approved | Investigational, not licensed | Investigational, not registered | Investigational, not approved |
| Note | Both components are investigational; the premixed blend is sold only by research chemical vendors and no compounding pharmacy or clinic supplies it. | Neither component is licensed; supply for human use is unlawful. | None recorded | None recorded |
US FDA status: Neither component is approved anywhere in the world. Both are investigational, and no regulator has evaluated the combination.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.